利妥昔单抗联合环磷酰胺、阿霉素、长春新碱及泼尼松方案治疗的原发性纵隔大B细胞淋巴瘤患者的PET/CT检查：106例患者预后意义分析及对后续放疗的影响 - Suppr

PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy.

作者信息

Vassilakopoulos T P, Pangalis G A, Chatziioannou S, Papageorgiou S, Angelopoulou M K, Galani Z, Kourti G, Prassopoulos V, Leonidopoulou T, Terpos E, Dimopoulou M N, Sachanas S, Kalpadakis C, Konstantinidou P, Boutsis D, Stefanoudaki E, Kyriazopoulou L, Siakantaris M P, Kyrtsonis M-C, Variami E, Kotsianidis I, Symeonidis A, Michali E, Katodritou E, Kokkini G, Tsatalas C, Papadaki H, Dimopoulos M-A, Sotiropoulos V, Pappa V, Karmiris T, Meletis J, Apostolidis J, Datseris I, Panayiotidis P, Konstantopoulos K, Roussou P, Rondogianni P

机构信息

Department of Haematology, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.

Department of Haematology, Athens Medical Center, Psychikon Branch, Athens, Greece.

出版信息

Leukemia. 2016 Jan;30(1):238-42. doi: 10.1038/leu.2015.120. Epub 2015 May 14.

DOI:10.1038/leu.2015.120

PMID:25971363

Abstract

摘要

相似文献

PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy.

Leukemia. 2016 Jan;30(1):238-42. doi: 10.1038/leu.2015.120. Epub 2015 May 14.

Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):113-21. doi: 10.1016/j.ijrobp.2015.02.006.

The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma.

Ann Hematol. 2014 Aug;93(8):1297-304. doi: 10.1007/s00277-014-2043-y. Epub 2014 Mar 5.

Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach.

Blood. 2020 Dec 10;136(24):2803-2811. doi: 10.1182/blood.2019004296.

[18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.

J Clin Oncol. 2014 Jun 10;32(17):1769-75. doi: 10.1200/JCO.2013.51.7524. Epub 2014 May 5.

Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.

Br J Haematol. 2017 Dec;179(5):739-747. doi: 10.1111/bjh.14951. Epub 2017 Oct 29.

Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).

J Clin Oncol. 2015 Aug 10;33(23):2523-9. doi: 10.1200/JCO.2014.58.9846. Epub 2015 Jul 6.

Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies.

Ann Hematol. 2021 Sep;100(9):2279-2292. doi: 10.1007/s00277-021-04421-2. Epub 2021 Feb 1.

Favorable outcome of primary mediastinal large B-cell lymphoma patients treated with sequential RCHOP-RICE regimen without radiotherapy.

Cancer Chemother Pharmacol. 2016 May;77(5):1053-60. doi: 10.1007/s00280-016-3024-8. Epub 2016 Apr 7.

Prognostic significance of rituximab and radiotherapy for patients with primary mediastinal large B-cell lymphoma receiving doxorubicin-containing chemotherapy.

Leuk Lymphoma. 2013 Aug;54(8):1684-90. doi: 10.3109/10428194.2012.746684. Epub 2012 Dec 5.

引用本文的文献

Optimally Delivered R-da-EPOCH Versus R-CHOP-21 in Primary Mediastinal Large B-Cell Lymphoma: A Real-Life Comparison in a Single Academic Center.

Cancers (Basel). 2025 May 19;17(10):1699. doi: 10.3390/cancers17101699.

Primary Mediastinal B-Cell Lymphoma and [18F]FDG PET/CT: What We Learned and What Is New.

Hematol Rep. 2025 Apr 28;17(3):23. doi: 10.3390/hematolrep17030023.

Cause-specific mortality in a population-level cohort of diffuse large B-cell lymphoma following chemotherapy in the early 21st century.

Ann Hematol. 2024 May;103(5):1675-1685. doi: 10.1007/s00277-024-05619-w. Epub 2024 Jan 16.

PET for Response Assessment to R-da-EPOCH in Primary Mediastinal Large B-cell lymphoma: Who Is Worthy to be Irradiated?

Hemasphere. 2023 Nov 7;7(11):e965. doi: 10.1097/HS9.0000000000000965. eCollection 2023 Nov.

Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional Study.

J Clin Med. 2023 May 31;12(11):3777. doi: 10.3390/jcm12113777.

Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee Collaboration.

Adv Radiat Oncol. 2022 Oct 3;8(1):101090. doi: 10.1016/j.adro.2022.101090. eCollection 2023 Jan-Feb.

High efficacy of intensive immunochemotherapy for primary mediastinal B-cell lymphoma with prolonged follow up.

Sci Rep. 2022 Jun 22;12(1):10551. doi: 10.1038/s41598-022-14067-3.

Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell Lymphoma.

In Vivo. 2022 May-Jun;36(3):1302-1315. doi: 10.21873/invivo.12831.

Very Early Onset of Therapy-Related Acute Myeloid Leukemia with 11q23 Rearrangement Presenting with Unusual PET Findings after R-DA-EPOCH for Primary Mediastinal Large B-Cell Lymphoma.

Medicina (Kaunas). 2021 Dec 29;58(1):48. doi: 10.3390/medicina58010048.

Dose-adjusted EPOCH-R is not superior to sequential R-CHOP/R-ICE as a frontline treatment for newly diagnosed primary mediastinal B-cell lymphoma: Results of a bi-center retrospective study.

Cancer Med. 2021 Dec;10(24):8866-8875. doi: 10.1002/cam4.4387. Epub 2021 Nov 24.

本文引用的文献

The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients.

Hematol Oncol. 2015 Dec;33(4):145-50. doi: 10.1002/hon.2172. Epub 2014 Sep 25.

Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.

J Clin Oncol. 2014 Sep 20;32(27):3048-58. doi: 10.1200/JCO.2013.53.5229.

A "PET" topic in primary mediastinal large B-cell lymphoma: positive or negative, and how to handle it in the end.

Leuk Lymphoma. 2015 Jan;56(1):3-5. doi: 10.3109/10428194.2014.929674. Epub 2014 Aug 4.

J Clin Oncol. 2014 Jun 10;32(17):1769-75. doi: 10.1200/JCO.2013.51.7524. Epub 2014 May 5.

The utility and limitations of (18)F-fluorodeoxyglucose positron emission tomography with computed tomography in patients with primary mediastinal B-cell lymphoma: single institution experience and literature review.

Leuk Lymphoma. 2015 Jan;56(1):49-56. doi: 10.3109/10428194.2014.910656. Epub 2014 Jun 16.

The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma.

Ann Hematol. 2014 Aug;93(8):1297-304. doi: 10.1007/s00277-014-2043-y. Epub 2014 Mar 5.

Radiation therapy in primary mediastinal B-cell lymphoma with positron emission tomography positivity after rituximab chemotherapy.

Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):311-6. doi: 10.1016/j.ijrobp.2013.05.053. Epub 2013 Aug 2.

Treatment of primary mediastinal B-cell lymphoma with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone is associated with a high rate of primary refractory disease.

Leuk Lymphoma. 2014 Mar;55(3):538-43. doi: 10.3109/10428194.2013.810738. Epub 2013 Jul 29.

Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.

N Engl J Med. 2013 Apr 11;368(15):1408-16. doi: 10.1056/NEJMoa1214561.

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care.

Oncologist. 2012;17(2):239-49. doi: 10.1634/theoncologist.2011-0275. Epub 2012 Jan 26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy.

作者信息

机构信息

Department of Haematology, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.

Department of Haematology, Athens Medical Center, Psychikon Branch, Athens, Greece.

出版信息

Leukemia. 2016 Jan;30(1):238-42. doi: 10.1038/leu.2015.120. Epub 2015 May 14.

DOI:10.1038/leu.2015.120

PMID:25971363

Abstract

摘要

PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献